MAPT and Alzheimer disease: Our results from western blot analysis and immunofluorescence staining showed a significant decrease in the levels of AD-related proteins such as Aβ42 and p-Tau in mice (Fig. 4C) and cells (Fig. 6A–C, F, G) with TFEB overexpression.